Dawn Faller/Linkedin
Apr 24, 2026, 17:35
Dawn Faller: Strengthening Global Collaboration in Apheresis at the 2026 ASFA and WAA Joint Meeting
Dawn Faller, Sr. Manager of Global Clinical Marketing at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
”Today we had the opportunity to welcome attendees of the 2026 ASFA and WAA Joint Meeting to the Terumo Blood and Cell Technologies Campus Headquarters ahead of the meeting kickoff.
This tour was a great opportunity to showcase the people and technologies behind our work.
It also highlighted how our teams at Terumo Blood and Cell Technologies are working alongside partners across the field to advance apheresis and help ensure blood remains an essential therapy for patients worldwide.
Looking forward to continuing these conversations throughout the conference.”
Stay updated with Hemostasis Today.
-
Sep 17, 2026, 20:38Konstantinos Bistas: Reduced Circulating Tregs in Pediatric Chronic Neutropenia
-
Sep 17, 2026, 15:33Gopal Patidar: Honoured to Contribute to the ASFA 2026 Guidelines for Therapeutic Apheresis
-
Sep 17, 2026, 20:36Cosima C. Hoch: Developing a 3D Organotypic Co-Culture Model for Pleomorphic Adenoma
-
Sep 17, 2026, 20:19Riten Kumar: Boston Children’s Hospital Ranked No. 1 in Seven Pediatric Specialties
-
Sep 17, 2026, 20:17Katrina Snow: Whole Blood or Component Therapy – Which Would You Choose?
-
Sep 17, 2026, 16:30Daria Camilli: Empowering Bleeding Disorder Advocacy Through Health Economics
-
Sep 17, 2026, 16:17Mehran Ghasemzadeh: Platelet NK Cell Crosstalk in Advanced Coronary Artery Disease
-
Sep 17, 2026, 16:16Barbara Adams Krolak: Do GLP-1s Affect Blood Clot Risk?
-
Sep 17, 2026, 15:46Heghine Khachatryan: Clinical Context at the Core of Thrombosis and Thrombophilia Management